Literature DB >> 15067311

Predicting the clinical course of prostate cancer.

James McKiernan1, Mitchell C Benson.   

Abstract

Risk stratification in prostate cancer remains a significant clinical challenge. A study in this issue of the JCI describes an exciting application of high-throughput functional genomic technology to further refine our understanding of treatment failure risk in prostate cancer patients.

Entities:  

Mesh：

Year:  2004        PMID： 15067311      PMCID： PMC362125          DOI： 10.1172/JCI21310

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  6 in total

1.  Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; S B Malkowicz; J Fondurulia; M H Chen; I Kaplan; C J Beard; J E Tomaszewski; A A Renshaw; A Wein; C N Coleman
Journal:  J Clin Oncol       Date:  1999-01       Impact factor: 44.544

2.  A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

Authors:  M W Kattan; J A Eastham; A M Stapleton; T M Wheeler; P T Scardino
Journal:  J Natl Cancer Inst       Date:  1998-05-20       Impact factor: 13.506

3.  Impotence following radical prostatectomy: insight into etiology and prevention.

Authors:  P C Walsh; P J Donker
Journal:  J Urol       Date:  1982-09       Impact factor: 7.450

4.  Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.

Authors:  M W Kattan; T M Wheeler; P T Scardino
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

5.  Malignancy-associated regions of transcriptional activation: gene expression profiling identifies common chromosomal regions of a recurrent transcriptional activation in human prostate, breast, ovarian, and colon cancers.

Authors:  Gennadi V Glinsky; Anja Krones-Herzig; Anna B Glinskii
Journal:  Neoplasia       Date:  2003 May-Jun       Impact factor: 5.715

6.  Gene expression profiling predicts clinical outcome of prostate cancer.

Authors:  Gennadi V Glinsky; Anna B Glinskii; Andrew J Stephenson; Robert M Hoffman; William L Gerald
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808
  6 in total
  1 in total

1.  Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers.

Authors:  B Xu; L Gao; L Wang; G Tang; M He; Y Yu; X Ni; Y Sun
Journal:  Br J Cancer       Date:  2013-08-15       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.